News
Twitter
Videos
Images
Events
News For Eli Lilly
This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google
24/05/2018 17:30:58
Why Is Eli Lilly (LLY) Up 2.7% Since Its Last Earnings Report? - Nasdaq
Nasdaq
Why Is
Eli Lilly
(LLY) Up 2.7% Since Its Last Earnings Report?
Nasdaq
A month has gone by since the last earnings report for
Eli Lilly
and CompanyLLY . Shares have added about 2.7% in that time frame. Will the recent positive trend continue leading up to its next earnings release, or is LLY due for a pullback? Before we
...
Eli Lilly's
Trulicity Benefits From Growth of Diabetes Drugs
TheStreet.com
Lilly's
cancer business loses its chief just as it's leaning on oncology for growth
FiercePharma
Sue Mahony to Retire as President of
Lilly
Oncology
PR Newswire (press release)
Post Analyst
-
Inside INdiana Business
all 90 news articles »
Google
24/05/2018 14:18:00
Merck data and a tumbling stock price cost Armo's investors $320M-plus in Eli Lilly buyout - Endpoints News
Endpoints News
Merck data and a tumbling stock price cost Armo's investors $320M-plus in
Eli Lilly
buyout
Endpoints News
Usually, being patient in an M&A deal is a big help to the seller. You never take the first offer. You always want more. In Armo's case, though, that first offer turned out to be significantly better than the final deal that was left on the table from
...
Google
24/05/2018 14:07:00
Teva, Eli Lilly to launch own migraine drugs to rival Aimovig - Born2Invest
Born2Invest
Teva,
Eli Lilly
to launch own migraine drugs to rival Aimovig
Born2Invest
Other companies involved in making migraine drugs are Allergan, Teva,
Eli Lilly
and Alder BioPharmaceuticals. Aimovig reduces migraine attacks by blocking the calcitonin gene-related peptide receptor, which is a major factor in causing migraine and
...
End of delay leaves Teva chomping at the bit to launch fremanezumab
The Pharma Letter
Teva hopes to launch migraine drug as soon as September
Reuters
Is This Little Biotech the Best Migraine Stock to Buy Now?
Motley Fool
all 15 news articles »
Google
24/05/2018 09:20:23
Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis - Zacks.com
Eli Lilly
Gets FDA Approval for Taltz in Genital Psoriasis
Zacks.com
Eli Lilly
& Company (LLY - Free Report) announced that the FDA has approved the inclusion of additional data on the label of its psoriasis injection, Taltz. With the latest approval, Taltz label will now include data for psoriasis involving the genital
...
and more »
Google
23/05/2018 14:02:53
BRIEF-Eli Lilly's Unit, Bluegill Acquisition Offering To Buy All Of Armo Biosciences's Outstanding Shares For $50/Share - Reuters
BRIEF-
Eli Lilly's
Unit, Bluegill Acquisition Offering To Buy All Of Armo Biosciences's Outstanding Shares For $50/Share
Reuters
May 23 (Reuters) - ARMO Biosciences Inc: * ARMO BIOSCIENCES -
ELI LILLY'S
UNIT, BLUEGILL ACQUISITION CORP, OFFERING TO BUY ALL OF CO'S OUTSTANDING SHARES FOR $50/SHARE - SEC FILING. * ARMO BIOSCIENCES - ON APRIL 13, ...
Google
23/05/2018 13:24:43
FDA OKs expanded label for Lilly's Taltz - Seeking Alpha
FDA OKs expanded label for
Lilly's
Taltz
Seeking Alpha
The FDA approves updated labeling for
Eli Lilly's
(NYSE:LLY) Taltz (ixekizumab) to include data on psoriasis in the genital area, the first time such data has been approved for inclusion for a medication for moderate-to-severe plaque psoriasis. Taltz
...
Google
22/05/2018 12:50:00
Eli Lilly's Positive Phase 3 Results Along With Recent Acquisitions Makes It A Force To Be Reckoned With - Seeking Alpha
Seeking Alpha
Eli Lilly's
Positive Phase 3 Results Along With Recent Acquisitions Makes It A Force To Be Reckoned With
Seeking Alpha
Eli Lilly
succeeds in one of two phase phase 3 studies in treating patients with cluster headaches using galcanezumab. Galcanezumab is also gearing up for an expected FDA decision by Q3 2018 for the prevention of migraines in adults.
Eli Lilly
has ...
Eli Lilly's
Cluster Headache Candidate Succeeds in Phase III
Zacks.com
all 10 news articles »
Google
16/05/2018 11:38:56
1
2